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Paradoxical low ﬂow, low gradient, severe aortic stenosis (AS) despite preserved ejection fraction is a recently described clinical entity
whereby patients with severe AS on the basis of aortic valve area have a lower than expected gradient in relation to generally accepted
values. This mode of presentation of severe AS is relatively frequent (up to 35% of cases) and such patients have a cluster of ﬁndings, indi-
cating that they are at a more advanced stage of their disease and have a poorer prognosis if treated medically rather than surgically. Yet, a
majority of these patients do not undergo surgery likely due to the fact that the reduced gradient is conducive to an underestimation of the
severity of the disease and/or of symptoms. The purpose of this article is to review and further analyse the distinguishing characteristics of
this entity and to present its implications with regards to currently accepted guidelines for AS severity.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
According to current ACC/AHA guidelines,
1 cut-off values for
Doppler-Echocardiographic measurements of severe aortic steno-
sis (AS) are deﬁned as follows: aortic valve area (AVA) ,1.0 cm
2
and/or indexed for body surface area ,0.6 cm
2/m
2, mean gradient
. 40 mmHg and peak velocity . 4.0 m/s (corresponding to a peak
gradient of 64 mmHg). It is not clear in the guidelines if these cri-
teria are mutually inclusive or exclusive but, as also stated in the
guidelines, ‘When stenosis is severe and cardiac output is
normal, the mean transvalvular pressure gradient is generally
greater than 40 mmHg.’ Hence, when LV function is normal, clini-
cians expect to see a high gradient in patients with severe AS as
well as consistency between the values proposed by the guidelines.
And indeed, typical reaction for the echocardiographer faced with
a lower than expected gradient in a patient with severe AS on the
basis of AVA would be to question the validity of the valve area
calculation, since this value is derived from multiple measurements
and thus more prone to error than gradient measurements.
Notwithstanding these considerations, it had long been our clini-
cal observation that many patients with severe AS on the basis of
AVA calculation indeed have unequivocally low gradients (e.g.
mean gradient , 30 mmHg) despite a preserved LV ejection frac-
tion (i.e. EF . 50%). Hence, we hypothesized that the lower gradi-
ents were likely due to a decrease in transvalvular ﬂow and, in a
recent study of 512 consecutive patients with severe AS
(indexed AVA ,0.6 cm
2/m
2) and preserved EF (.50%), we
found that 35% had paradoxically low ﬂows (PLF) [i.e. stroke
volume index (SVi) ,35 mL/m
2].
2 The same patients were also
observed to have a cluster of ﬁndings suggesting that they were
at more advanced stage of their disease and had a worse prognosis
if treated medically rather than surgically. In the same context,
Minners et al.
3 reported a series of 2427 consecutive patients
with preserved LV function and AVA ,2.0 cm
2 and found that,
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doi:10.1093/eurheartj/ehp361in reference to the guidelines, 30% had the inconsistent ﬁnding of
an AVA ,1.0 cm
2 but a mean gradient ,40 mmHg. On the basis
of a previous observation by Carabello (Table 1),
4 these authors
also emphasized that, based on the Gorlin formula and assuming
normal cardiac output, an AVA of 1.0 cm
2 yields a gradient of
26 mmHg and that an AVA  0.81 cm
2 is necessary to yield a gra-
dient  40 mmHg, thus suggesting that it is the guidelines per se
that are inherently inconsistent. In a further comment, Jander
5
observed that low ﬂow was thus not a necessary prerequisite
for inconsistently low gradients and suggested an adjustment of
the AVA cut-off value for severe stenosis to 0.8 cm
2. The same
author also hypothesized that many patients with low ﬂow may
nonetheless have gradients .40 mmHg.
Because of our previous demonstration
2 that patients with PLF
severe AS despite preserved EF are often misdiagnosed and have a
poor prognosis if not operated, the present article purports to
review the distinguishing characteristics of this entity in order to
optimize its diagnosis and treatment and improve survival. Given
the questions raised by Jander
5 in relation to the interpretation
of data in individual patients, we also proceeded to re-analyse
our previous data within the context of the cut-off values pro-
posed by the guidelines.
1 In this as well as in our previous
2
paper, the term ‘paradoxical’ does not refer to intrinsic physiology
but rather to the frequent misconception by clinicians that patients
with AS and normal EF necessarily have normal ﬂow (NF).
Distinguishing features of paradoxically
low ﬂow patients
Patients with PLF severe AS despite a preserved EF are identiﬁed
as those presenting with an indexed AVA ,0.6 cm
2/m
2,a nE F.
50%, and a SVi ,35 mL/m
2. Both AVA and indexed AVA are pro-
posed in the ACC/AHA guidelines (see Table 4 of Bonow et al.
1)a s
valid indicators of AS severity. The rationale for using indexed AVA
is particularly relevant in this situation. Indeed, using non-indexed
values, patients with a small body surface area (BSA) and a low gra-
dient due to a lower albeit normal cardiac index could otherwise
have been misclassiﬁed as having PLF severe AS when in fact,
relative to BSA, ﬂow is normal and the AS is only moderate.
Notwithstanding these considerations, compared with patients
with NF, patients with PLF have markedly lower gradients to the
extent that in our study, 55% had a mean gradient ,30 mmHg.
2
Apart from these ﬁndings, other distinguishing features of PLF
patients when compared with NF patients are: (i) a higher level
of global LV haemodynamic load reﬂected by higher
valvulo-arterial impedance (Zva); (ii) smaller and relatively thicker
ventricles; (iii) lower values for LV mid-wall radius shortening con-
sistent with more pronounced intrinsic myocardial dysfunction,
and (iv) a tendency to have a lower LVEF although remaining
within the normal range. Overall, these ﬁndings are consistent
with a greater and probably more long standing increase in LV
haemodynamic load resulting in more pronounced concentric LV
remodelling, a smaller LV cavity size and a decrease in intrinsic
myocardial function. This observation is further conﬁrmed by the
fact that overall, these patients have a signiﬁcantly poorer progno-
sis than patients with NF; as well, their prognosis is also much
poorer if treated medically rather than surgically.
2 Nonetheless,
the proportion of these patients referred for surgery is much
lower than in their counterparts with the more classical NF high
gradient pattern of AS. Although symptomatic status was not avail-
able, this result strongly suggests that, due to the lower gradients,
the condition may often be misdiagnosed, which leads to underes-
timation or neglect of symptoms and inappropriate delay of aortic
valve replacement (AVR).
Corroborating studies
The SEAS trial was a large randomized prospective study examin-
ing the effects of a combined simvastatin and ezetemide treatment
vs. placebo in 1873 asymptomatic patients with moderate AS on
the basis of peak transvalvular velocity. In a recent sub-study,
6
these investigators speciﬁcally analysed their data for the presence
of low ﬂow severe AS and using parameters analogous to those
reported in the study of Hachicha et al.,
2 reported a prevalence
of 28% (100 patients) among the 359 patients found to have
severe AS. Moreover, these patients had a signiﬁcantly increased
global LV load, smaller LV volumes, more concentric remodelling,
and decreased mid-wall shortening compared with NF patients;
mean gradient was ,30 mmHg in 56% of the patients. Overall,
these ﬁndings are most consistent with the data of Hachicha
et al.
2 and conﬁrm that this is not a rare occurrence and indeed
represents a more advanced stage of the disease. Very similar
results are also reported by Barasch et al. who found a prevalence
of 22% in 215 patients and also observed that a mean gradient
,30 mmHg was associated with an almost 50% lower referral to
surgery and a higher mortality rate.
Physiopathology of paradoxically low
ﬂow aortic stenosis despite preserved
ejection fraction
The more pronounced concentric LV remodelling and smaller LV
cavity size found in PLF patients is akin to a restrictive physiology.
Indeed, the decrease in stroke volume is primarily due to deﬁcient
................................................................................
Table 1 Relation of the aortic valve area to the
gradient
Aortic valve area (cm
2) Mean gradient (mmHg)
4 1.7
3 2.9
2 6.6
12 6
0.9 32
0.8 41
0.7 53
0.6 73
0.5 105
Reproduced with permission from Carabello
4. Data were derived with the Gorlin
formula:
Aortic valve area ¼
cardiac output 4 ðsystolic ejection period   heart rateÞ
44:3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mean gradient
p
J.G. Dumesnil et al. 282ventricular ﬁlling in relation with the smaller cavity size rather than
deﬁcient ventricular emptying. Nonetheless, in many patients, the
problem is further compounded by the presence of intrinsic myo-
cardial dysfunction causing the EF, albeit normal, to be lower (i.e.
50–60%) than expected in similar situations. Indeed, patients
with severe AS and LV concentric remodelling often tend to
have relatively higher EF’s than normal (e.g. .70%) to compensate
for the insufﬁciency in ventricular ﬁlling.
7 The latter observation
illustrates that a normal LVEF should not be construed as being
equivalent to normal LV ﬂow output and that it may indeed
remain normal despite a signiﬁcant reduction in intrinsic myocar-
dial shortening. As well, it emphasizes that the evaluation of LV
function should be more comprehensive and includes parameters
(e.g. mid-wall radius shortening, longitudinal shortening, myocardial
strain rate) going beyond the characterization of LV emptying.
Contribution of vascular component
to increased global left ventricular
haemodynamic load
The most frequent cause of AS nowadays is degenerative AS and
there is an increasing body of evidence, suggesting that it is an
active process akin to atherosclerosis.
8,9 Thus, patients with degen-
erative AS often have other manifestations of atherosclerosis
including a decrease in systemic arterial compliance due to
increased rigidity of the arterial wall, which in the presence of
normal LV stroke volume, translates into the presence of concomi-
tant systolic hypertension. As well, such patients may also have
alterations in LV function which might not only be due to AS
but also to hypertension or associated coronary artery disease
and in varying proportions depending on the severity of each
entity. In this context, it should be emphasized that the pathophy-
siology of adverse outcomes in AS is essentially due to an imbal-
ance between the increase in LV haemodynamic load and the
capacity of the left ventricle to overcome this increase in load
both at rest and during exercise. Hence, if the disease is limited
to the valve, severity can be described in relatively simple terms
such as AVA and gradients. However, if the disease is not limited
to the valve but also involves the vascular system, systemic arterial
compliance and systemic vascular resistance should also be taken
into consideration.
In a recent study of 208 consecutive patients with at least mod-
erate AS, systemic arterial compliance was reduced in 41% of sub-
jects and had an additive effect to the extent that patients with the
combination of decreased arterial compliance and moderate AS
had levels of global LV haemodynamic load as elevated as patients
with severe AS and normal compliance.
10 These ﬁndings empha-
size that the LV in degenerative AS is often facing a double load,
i.e. valvular plus vascular. In this context, it was recently proposed
to quantify global LV haemodynamic load by calculating Zva, which
is obtained by dividing estimated LV systolic pressure by the SVi.
Conceptually, this parameter represents the cost in mmHg for
each millilitre of blood indexed for body surface area pumped by
the left ventricle. Zva can easily be estimated during Doppler-
echocardiography by adding the mean aortic gradient to the per-
ipheral LV systolic pressure measured by sphygmomanometry
and dividing the result by SVi and it has been shown to be superior
to the standard indices of AS severity in predicting LV dysfunction
and patient outcome.
2,10 Zva might be viewed as an oversimpliﬁca-
tion from a fundamental standpoint but is, nonetheless, the best
available parameter to routinely quantify overall haemodynamic
load in the clinical situation.
11
It is also interesting to note that PLF patients have markedly
higher values for Zva than NF patients and that this increase is
largely due to a more pronounced decrease in systemic arterial
compliance than to an increase in AS severity. Since the increase
in LV wall thickness in hypertension not only represents physiologi-
cal hypertrophy in response to the increased load but may also
involve neuro-hormonal mechanisms leading to interstitial ﬁbrosis,
one might speculate that this factor might contribute to the more
pronounced LV concentric remodelling seen in these patients; as
well, it might also contribute to a greater decrease in intrinsic myo-
cardial function.
With regards to the clinical presentation of patients with AS and
a decrease in systemic arterial compliance, the following consider-
ations also need to be emphasized. (i) The signs of AS severity can
be masked by the presence of concomitant hypertension, particu-
larly if associated with a signiﬁcant decrease in systemic arterial
compliance; indeed, decreased compliance tends to abolish the
peak-to-peak gradient as recorded during catheterization and
may also modify other signs of AS severity.
12,13 (ii) Peripheral
blood pressure and systemic arterial compliance are important
considerations with regards to total haemodynamic load in these
patients; these parameters should thus become an integral part
of their evaluation, the practical implication being that blood
pressure should routinely be measured at the time of the echocar-
diogram in every patient with AS. (iii) Because compliance and
impedance are not constants but vary with the level of blood
pressure and given that the signs of AS severity may be partially
masked by hypertension, evaluations of AS severity should ideally
be performed when blood pressure control is optimal to the
extent that the examination should be deferred or repeated if
the patient is hypertensive at the time of the ﬁrst evaluation. (iv)
Progression of valvulo-arterial disease may eventually result in a
pseudo-normalization of blood pressure due to a reduction in
stroke volume. In our patients with PLF,
2 average blood pressure
was 131/74 mmHg despite a severe decrease in arterial compli-
ance. Pseudo-normalization of blood pressure is thus a frequent
phenomenon in these patients and a normal blood pressure
reading should not be construed to be equivalent with a normal
vascular load. (v) Pathophysiology of low ﬂow in these patients is
essentially due to concentric remodelling and diastolic dysfunction
in relation to restrictive LV ﬁlling and in some patients, it may be
difﬁcult to precisely delineate the relative contributions of AS
and hypertension to the changes in ventricular geometry and
function. This consideration may become relevant with regards
to treatment in patients with marked decrease in systemic arterial
compliance and borderline criteria for severe AS and it cannot be
excluded that some of these patients may even have ‘pseudo-
severe AS’ due to low ﬂow. In such cases, dobutamine stress echo-
cardiography and other diagnostic modalities such as quantiﬁcation
of valve calciﬁcation by multidetector computed tomography
might prove useful although there is at present very little experi-
ence with regards to their utilization in this context.
Low ﬂow low gradient severe AS with preserved EF 283Illustrative case
Figure 1 presents the case of a 57 y.o. male with a systolic
murmur and typical class III/IV angina for more than 1 year.
The two-dimensional echocardiogram shows a heavily calciﬁed
aortic valve, small LV cavity (38 mL/m
2) and marked LV
concentric remodelling (wall thickness to radius ratio ¼ 0.56).
Maximal and mean gradients by Doppler are 38 and 22 mmHg,
respectively, whereas AVA is 0.99 cm
2, indexed AVA
0.45 cm
2/m
2, SVi 30 mL/m
2, Zva 5.73 mmHg/mL/m
2, and EF 72%.
On the basis of these results, the patient was identiﬁed as a PLF
AS and referred to surgery. Cardiac catheterization prior to AVR
showed the following results: LV systolic pressure 175 mmHg, LV
end-diastolic pressure 35 mmHg, aortic pressure 150/76,
peak-to-peak gradient 25 mmHg, AVA 0.95 cm
2, indexed AVA
0.43 cm
2/m
2; coronary angiography revealed a 25% stenosis on
the distal LAD. A heavily calciﬁed stenotic valve was found at
operation, AVR was performed and post-operative course was
uneventful with no recurrence of symptoms. It should be
emphasized that patient had been seen 1 year earlier with similar
symptoms and ﬁndings but had been dismissed on medical treat-
ment because of underestimation of AS severity due to the low
gradients.
Interpretation of results within the
context of guidelines
In view of the important questions raised by Jander
5 and their
potential implications with regards to prognosis and treatment,
we elected to further analyse our previously reported data
2
within the context of the cut-off values proposed by the guide-
lines.
1 Hence, our 512 consecutive patients with severe AS
(indexed AVA   0.6 cm
2/m
2) and preserved EF (.50%) were sub-
divided into four subgroups based on the presence of normal or
paradoxical low ﬂow (i.e. SVi more than or  35 mL/m
2) and
high or low gradient (i.e. mean gradient more than or
 40 mmHg). Figure 2 is the result of this analysis. Of interest is
the fact that ﬁnally only 38% of patients (i.e. those represented
Figure 1 Illustrative case of patient with PLF AS. (A) Pulse wave (PW) Doppler tracing in LV outﬂow tract; ITV, time velocity integral; VE,
stroke volume; FE, ejection fraction; SVi, stroke volume index. (B) Continuous wave (CW) Doppler tracing through aortic valve; GP, pressure
gradient; SVA, aortic valve area; SVAind, aortic valve area indexed for body surface area. (C) Two-dimensional echocardiogram in the paraster-
nal long-axis view in diastole showing heavily calciﬁed valve and small LV with concentric hypertrophy. (D) Pullback pressure tracing from LV to
aorta; see text for details.
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are fully consistent with the criteria proposed by the guidelines
with regards to indexed AVA and mean gradient, whereas 62%
(i.e. Groups 2 ‘NF, low gradient’ and 4 ‘low ﬂow, low gradient’)
had a lower than expected gradient i.e. ,40 mmHg. As well,
indications for operation appear to be much more driven by
the presence of a high gradient than a low AVA. Indeed, AVR
was performed in 80 and 68% of patients in Groups 1 and 3,
respectively, whereas only 53 and 36% of patients underwent
operation in Groups 2 and 4, respectively. Overall, the patients
treated surgically were signiﬁcantly younger (68+12 vs. 74+
14 y.o., P , 0.001) and comprised a higher proportion of
females (62 vs. 50%, P , 0.006) than the patients treated medi-
cally, whereas there were no signiﬁcant differences between
the two groups for LVEF or the presence of hypertension, coron-
ary artery disease, or diabetes. Figure 3 provides survival curves in
each subgroup as a function of treatment: medical vs. surgical and
shows that in each case, prognosis is signiﬁcantly better if oper-
ated than if treated medically. The results in Group 2 ‘NF, low
gradient’ are of particular interest since, in relation to guidelines,
these patients can be deemed to have an inconsistently low gra-
dient that is not due to low ﬂow but rather to the previously
mentioned inherent inconsistency contained in the guidelines,
i.e. that in a patient with NF, an AVA of 1.0 cm
2,o r0 . 6c m
2/m
2
will theoretically yield a mean gradient of 26 mmHg rather than
40 mmHg.
3 For this reason, it has been hypothesized that these
patients might not have truly severe AS and that it might thus
be appropriate to re-adjust the cut-off value for severe AS to
0.80 cm
2 rather than 1.0 cm
2.
3,5 The present results, however,
show that although the degree of AS severity is less in these
patients than in the other groups, their prognosis is nonetheless
signiﬁcantly worse if treated medically rather than surgically.
Similar results have recently been observed by the Mayo clinic
group (M. Enriquez-Sarano, personal communication) whereby,
regardless of gradient, patients with an AVA  1.0 cm
2 have a sig-
niﬁcantly worse prognosis if not operated. At the other end of
the spectrum are the patients in Group 3 ‘low ﬂow, high gradient’
who have much more severe stenosis to the extent that despite
low ﬂow, their gradients are .40 mmHg. Their tendency to have
a better survival if treated surgically than the patients in Group 4
who have less severe stenosis is intriguing but might indicate
better cardiac reserve to the extent that they have been able
to survive up to that level of severity. Indirectly, the higher peri-
operative mortality observed in the Group 4 patients (Figure 3D)
Figure 2 Characterization of 512 consecutive patients with severe AS (AVAi ,0.6 cm
2/m
2) and preserved ejection fraction (.0.50) based on
for SVi . or  35 mL/m
2 and mean pressure gradient . or  40 mmHg (data taken from Hachicha et al.
2). AVA, aortic valve area; AVR, aortic
valve replacement; LVEDD, left ventricular end-diastolic diameter; LVDEVI, left ventricular end-diastolic volume index; SVi, stroke volume index;
Zva, valvulo-arterial impedance.
Low ﬂow low gradient severe AS with preserved EF 285could also be consistent with this hypothesis, i.e. that the latter
patients have less myocardial reserve than the Group 3 patients
(Figure 3C).
The number of events per group is too small to allow separate
multivariate analysis in each subgroup. Hence, we elected to
perform a multivariate Cox proportional hazard analysis in the
whole cohort which includes the variables that were signiﬁcantly
different between the medically and surgically treated patients
(i.e. age, gender, gradient), the variables that were predictive of
mortality on univariate analysis (i.e. age, LVEF, Zva, treatment:
medical vs. surgical) and the variables that were the main distinc-
tive features between the four groups (i.e. SVi and gradient).
After adjustment for these seven variables, AVR did indeed
remain associated with a powerful protective effect [HR: 0.29
(95% CI: 0.15–0.54), P , 0.0001]. In the same line, these results
are also to a large extent supported by the aforementioned
observations at the Mayo Clinic and the results of Barasch
et al.
14 who showed that, in patients with an indexed AVA
,0.6 cm
2/m
2, the presence of a mean gradient ,30 mmHg is
associated with almost 50% lower referral to surgery and a
two-fold increase in mortality compared with patients with
higher gradients. As well, Pai et al.
15 recently reported that patients
with severe AS on the basis of AVA, low gradient (,30 mmHg),
and preserved LVEF had signiﬁcantly better survival when treated
surgically than when treated medically (5 year survival 90% vs.
20%, P , 0.0001). Overall, these ﬁndings conﬁrm that the
present AVA and indexed AVA cut-off values for severe stenosis
appear to be adequate regardless of gradients and that, unfortu-
nately, due to the lower gradients, this condition is often misdiag-
nosed, which leads to underestimation or neglect of symptoms and
inappropriate delay of AVR. Hence, this entity of low ﬂow low
gradient AS despite preserved EF is particularly important to
Figure 3 Overall survival in the four groups of patients (Figure 2) as a function of the type of treatment: medical vs. surgical (data taken from
Hachicha et al.
2).
J.G. Dumesnil et al. 286recognize, so that we do not deny surgery to a symptomatic
patient with a low pressure gradient.
Comprehensive evaluation of aortic
stenosis severity
Table 2 is a list of the various parameters which in our opinion
should be measured during a comprehensive Doppler-
echocardiographic examination for AS. In particular, peripheral
blood pressure should be recorded in every patient, and systemic
arterial compliance and valvulo-arterial impedance routinely calcu-
lated. This will add little time to the examination, since the only
additional measurement to be performed is peripheral blood
pressure which should ideally be performed at the same time as
the LV stroke volume and transvalvular gradient measurements.
Such parameters provide essential information in patients with dis-
crepant measurements. In this context, it should be reiterated that
the classical markers of AS severity may be blunted in the presence
of hypertension, whereas blood pressure may be pseudo-
normalized in patients with high haemodynamic load and low
stroke volume.
2,10,12,16 Moreover, the discovery of high impedance
(i.e. .4.5 mmHg/mL/m
2) might provide an explanation for other-
wise unexplained symptoms in patients with the combination of
moderate AS and decreased arterial compliance (i.e. ,0.6 mL/
mmHg/m
2); such a combination was found in 24% of patients by
Briand et al.
10 and the impacts on LV function were as pronounced
as those observed in patients with the combination of severe AS
and normal arterial compliance. Although beyond the scope of
the present topic, it should be mentioned that the energy loss
index is a parameter akin to the indexed AVA but taking into
account pressure recovery;
17 from a practical standpoint, it is
most useful in patients with a small aortic diameter (,30 mm)
where the recorded gradients and AVA may signiﬁcantly overesti-
mate AS severity.
18,19 Cut-off value for severe AS using the energy
loss index is ,0.55 cm
2 m
2.
17
The main pitfall associated with the echocardiographic diagnosis
of paradoxical low ﬂow and/or low gradient AS is an error in the
calculation of the stroke volume. Indeed, this measurement is
included in the calculation of many parameters including AVA,
systemic arterial compliance, and valvulo-arterial impedance;
moreover, it is derived from two separate measurements [left
ventricular outﬂow tract (LVOT) diameter and LVOT time–
velocity integral] having each their potential for error. Hence, we
would suggest the following veriﬁcations be done when con-
fronted with a possible diagnosis of PLF AS: (i) measurements
for LVOT diameter and LVOT time–velocity integral as well as
transvalvular velocities should be re-checked for accuracy; (ii)
the EF calculated by the Dumesnil method
20 is obtained by dividing
the LVOT stroke volume by the LV end-diastolic volume calculated
from the LV end-diastolic diameter using the Teicholz formula;
hence, a result consistent with that obtained by other means of cal-
culating EF (e.g. Simpson method, Quinones, eyeball, etc.) is indir-
ect and independent conﬁrmation that the measure for stroke
volume is valid, whereas a value lower than expected can
suggest that the LVOT stroke volume is underestimated due to
an error in measurement; an important caveat is, however, that a
low EF by the Dumesnil method can also be encountered in
patients with signiﬁcant mitral regurgitation, because a signiﬁcant
proportion of the total LV stroke volume is ejected through the
mitral valve rather than the aortic valve. (iii) LV geometry measure-
ments should be reviewed with the expectation of ﬁnding a small
LV cavity (LV end-diastolic internal diameter ,50 mm and/or LV
end-diastolic volume index ,60 mL/m
2) and a noticeable increase
in relative wall thickness ratio (i.e. .0.45). In patients having per-
sistent ambiguities or discrepancies on their echocardiograms,
cardiac magnetic resonance imaging may also be used to validate
LV geometry and stroke volume measurements. As a footnote, it
should be noted that, in Hachicha et al.,
2 the stroke volume
measured by Doppler in the LVOT was validated by independent
calculations made using Simpson’s method, whereas the SEAS trial
sub-study utilized yet another method i.e. the stroke volume using
the Teicholz correction of the cube formula and that both studies
reported a similarly high prevalence for PLF AS. Hence, it is very
unlikely that the prevalence of this syndrome has been overesti-
mated due to underestimation in stroke volume measurements.
Finally, it should be emphasized that less active elderly patients
mayhaveatendencytominimizetheirsymptomsandthatthissenti-
mentmayevenbere-enforcedbytheirtreatingphysicianwhenheor
she is confronted with a relatively low gradient on the echocardio-
gram. In such patients, recent studies have shown that exercise
testingisbothsafeandusefulinconﬁrmingorinﬁrmingthepresence
of symptoms.
21,22 Moreover, such evaluations may also be helpful in
convincing both patient and physician that the situation is more
serious than previously thought. As well, recent studies also show
that measurements of plasma brain natriuretic peptides
23,24 and
................................................................................
................................................................................
................................................................................
................................................................................
Table 2 Comprehensive Doppler-echocardiographic
examination of aortic stenosis
Quantiﬁcation of valvular obstruction
Maximal velocity
Mean gradient
Aortic valve area
Indexed aortic valve area
Energy loss index
Quantiﬁcation of vascular load
Peripheral blood pressure
Systemic arterial compliance
Systemic vascular resistance
Quantiﬁcation of global LV haemodynamic load
Valvulo-arterial impedance
Quantiﬁcation of LV geometry
LV end-diastolic internal diameter
LV end-diastolic volume index
Relative wall thickness
Quantiﬁcation of LV systolic function
LVOT stroke volume index
Cardiac index
Ejection fraction by Simpson method
Ejection fraction by Dumesnil method
Mid-wall fractional shortening
Low ﬂow low gradient severe AS with preserved EF 287quantiﬁcationofvalvecalciﬁcationbymultidetectorcomputedtom-
ography
25,26 may also be useful in conﬁrming AS severity.
Clinical implications
The main implication of these considerations is that the diagnosis of
severe AS should be based on results for AVA and indexed AVA
rather than on gradients. Pending further conﬁrmation and given
the presently available outcome data, present cut-off values for
these variables also appear to be adequate. Hence, notwithstanding
contraindications due to co-morbidities or refusal of the patient,
whichisnotinfrequentinelderlypatients,theappropriatetreatment
in a symptomatic patient with an AVA ,1.0 cm
2 and/or an indexed
AVA ,0.6 cm
2/m
2 is deﬁnitely to proceed with an AVR. In patients
with low ﬂow AS and preserved EF, the aortic annulus may be
smaller than expected due to the marked concentric remodelling
and the smaller LV cavity and the prevention of valve prosthesis-
patient mismatch may thus become more challenging. As well, the
restrictive physiology observed in these patients may possibly pre-
disposetohypotensionandlowoutputfailureaftercomingoffextra-
corporeal circulation as well as to higher peri-operative mor-
tality.
27,28 Notwithstanding these considerations, the results none-
theless clearly show that these patients have a much better
prognosis if treated surgically than medically.
2,15 Moreover, the
rapidly evolving ﬁeld of percutaneous valve implantation will prob-
ably become an attractive alternative in patients considered to be
at higher risk with regards to prosthesis-patient mismatch and/or
peri-operative mortalityas well as in more elderly patients reluctant
to undergo open heart surgery.
29,30
Unanswered questions include deﬁnition of the optimal medical
treatment in patients with concomitant systolic hypertension due
to decreased systemic arterial compliance. Indeed, such treatment
may often be of limited efﬁcacy given that the peripheral systolic
pressure may remain high despite an adequate pharmacological
treatment and a normal or low diastolic pressure (e.g. 160/
60 mmHg). In this context, the cases of patients with the combi-
nation of moderate AS and decreased systemic arterial compliance
who remain symptomatic despite optimal medical treatment are
particularly challenging. Indeed, it might eventually be found that
some of these patients might actually beneﬁt from operation
although not meeting the currently accepted criteria for AS sever-
ity, the rationale being that their total LV haemodynamic load is
markedly increased and that any signiﬁcant decrease might contrib-
ute to improve their prognosis and well being. In contemplating the
surgical option, indications that the operation is likely to result in
signiﬁcant beneﬁt should, however, be sought by estimating for
instance the relative contributions of the valvular and vascular
loads to the increased haemodynamic load. In this context, particu-
lar care should also be taken to avoid prosthesis–patient mismatch
in order to obtain the optimal decrease in valvular load.
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